Why ASML Stock Fell as AI Leaders Called for a Slowdown

ASML’s September 14 decline was principally a reassessment of the long-term AI investment story. After Anthropic chief executive Dario Amodei called for a slower pace of frontier-AI development, with support reported from OpenAI’s Sam Altman and Elon Musk, investors sold companies whose valuations rely on sustained spending for AI chips, servers and data centers. ASML’s Amsterdam-listed shares fell about 5.2%, while its U.S.-listed shares were reported down roughly 7.3%. 24

Why a debate about AI safety hit ASML

ASML makes lithography systems used to manufacture advanced semiconductors. A voluntary or regulatory slowdown in the improvement of frontier models would not automatically mean fewer machines are needed tomorrow. But it could make investors question the eventual scale and pace of data-center construction, leading-edge chip production, and equipment purchases.

That is why the move looked like a risk-premium and valuation reset, rather than a reaction to an earnings miss, a cancelled order or a disclosed change in ASML’s operating outlook. The market was reducing the value it was willing to place on future AI-driven growth.

Semiconductor stocks took the brunt of the sell-off

The reaction was global. Reuters reported that AI-linked shares fell from Asia to the U.S., with chipmakers among the largest decliners. 17 In the U.S., the PHLX semiconductor index fell 5.9%; Nvidia declined 3.4%, Micron dropped more than 5%, and Broadcom and AMD each lost more than 4%. 27

Other AI-infrastructure names also weakened. CNBC reported declines of more than 4% for Intel, Marvell and Applied Materials, while SK Hynix fell 7% in U.S. trading. 20 The damage was not evenly distributed across technology: Reuters reported that U.S. chip stocks bore the brunt of the sell-off while software names rallied. 19

The broader market finished lower but was less severely affected:

• S&P 500: down 0.48%
• Nasdaq Composite: down 0.56%
• Dow Jones Industrial Average: down 0.29% 18

That contrast matters. The market was not treating the event as a broad recession signal; it was concentrating the reassessment in companies most exposed to an AI infrastructure build-out.

The valuation concern behind the ASML reaction

ASML’s technology position was not the issue. The more immediate concern was the price investors had been paying for a demanding growth path.

Morgan Stanley cut its ASML price target to €1,700 from €1,930 while keeping an Overweight rating, citing near-term China exposure and margin risks. 13 That combination illustrates the distinction: an analyst can remain constructive on the company while arguing that the stock leaves less room for disappointment.

For a company valued on years of exceptional AI-related capital expenditure, even a modest reduction in assumptions about future customer spending, machine shipments or margins can produce an outsized share-price move. The September 14 event put that sensitivity on display.

Why JPMorgan and Bernstein remained constructive

The sell-off occurred alongside evidence that ASML’s demand outlook had not yet deteriorated.

After meeting ASML’s CFO, JPMorgan said management indicated that AI demand remained “very very strong.” The analysts said ASML was examining ways to produce more than 110 EUV systems in 2028, and Reuters reported that ASML was nearly sold out of those machines for 2027. 1

EUV—extreme ultraviolet lithography—is central to the production of leading-edge chips. If customers are reserving capacity well ahead of delivery, the near-term issue can be ASML’s ability to build systems rather than customers’ willingness to buy them.

Bernstein’s analysis similarly reflected a bullish view of AI-driven expansion in advanced logic and DRAM manufacturing. The firm raised its EUV shipment estimates to 91 systems for 2027 and 113 for 2028, from prior estimates of 86 and 87, respectively, while maintaining an Outperform rating. 51 Those are analyst forecasts, not ASML commitments, but they explain why some investors saw the sell-off as disconnected from the company’s near-term order visibility.

ASML also said its 2027 and 2028 capacity planning included expected demand related to Elon Musk’s proposed Texas Terafab project. That acknowledges the project in planning assumptions; it should not be read as confirmation of future booked revenue. 49

ASML’s reported fundamentals still pointed upward

ASML’s second-quarter results provided the clearest company-supplied counterpoint to the market’s concern. The company reported €9.3 billion in net sales and €2.9 billion in net income for Q2 2026. 40

It also raised its full-year 2026 net-sales outlook to €43 billion to €45 billion, with expected gross margin of 54% to 56%. 40 For the third quarter, ASML guided for €11 billion to €12 billion in net sales and gross margin of 55% to 57%. 40

Management’s capacity plans were equally notable. ASML said it planned to add 30% to its 2026 Low-NA EUV capacity of about 65 systems for 2027 and was investigating another 30% increase for 2028. It described the same 30%-then-potentially-30% expansion approach for DUV immersion capacity. 40

These disclosures do not eliminate risks from a slower AI build-out, export controls, customer timing or margins. They do establish that, at the time of the sell-off, ASML had not announced a cut to its guidance or capacity plans.

What the next results need to show

The next quarterly update is the practical test of whether September 14 was mostly a sentiment shock. Investors will be watching for:

1. Delivery against Q3 guidance of €11 billion to €12 billion in sales and 55% to 57% gross margin. 40
2. Unchanged or improved visibility into 2027 and 2028 EUV demand and production capacity.
3. Customer spending commentary for advanced logic and memory, where AI-related demand is concentrated.
4. Any evidence of delays or softer demand, such as weaker forward order commentary, reduced capacity ambitions or delivery deferrals.

A result in line with guidance, coupled with continued confidence in EUV demand, would support the interpretation that the decline was mainly a repricing of a high-expectation stock. A weaker outlook or materially softer customer commentary would instead suggest that the market’s concerns about slower AI infrastructure spending are beginning to affect ASML’s business.

The distinction is essential: the September sell-off reflected a possible change in the future AI-capex narrative. ASML’s results, capacity plans and customer demand signals will determine whether that narrative becomes an observable slowdown.